Intelligence · Clinical Development
Pipeline search results
Programs matching “heparin” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 9 pipeline programs matching "heparin" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
ATN-108
Lacuna Pharma Pty Ltd
Acquired Antithrombin Deficiency (Heparin Resistance)
1 trial -
HEPARIN , NADROPARIN
Disc Medicine
All patients who receive ECMO treatment during the study period in one the participating centers from which (deferred) informed consent is obtained. Patients in whom the ECMO is only used to bridge a procedure like a high risk percutaneous coronary intervention or during surgery are excluded.
1 trial -
Heparin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Thromboprophylaxis
1 trial -
Heparin and Rivaroxaban
The First People's Hospital of Lianyungang
Liver Cirrhosis
1 trial -
Low Molecular Weight Heparin (LMWH)
Cardiff Oncology
Cancer
1 trial -
Low-Molecular-Weight Heparins Calcium Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pneumonia
1 trial -
Heparin Sodium
The First People's Hospital of Lianyungang
Cerebral Aneurysm
1 trial -
Unfractionated heparin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary PCI
1 trial -
routine aspirin and heparin treatment
The First People's Hospital of Lianyungang
Acupuncture
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.